Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 20490536)

1.

Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium.

Donaldson C, Taatjes DJ, Zile M, Palmer B, VanBuren P, Spinale F, Maughan D, Von Turkovich M, Bishop N, LeWinter MM.

Histochem Cell Biol. 2010 Jul;134(1):23-30. doi: 10.1007/s00418-010-0706-x. Epub 2010 May 19.

PMID:
20490536
2.
3.

Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.

Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S, Itabe H, Takano T.

Atherosclerosis. 1998 Nov;141(1):61-75.

PMID:
9863539
4.

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.

Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S.

Biochemistry. 1996 Jun 18;35(24):8075-83.

PMID:
8672512
5.

Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation.

Yoshida S, Yamada K, Hamaguchi K, Nishimura M, Hatakeyama E, Tsuchida H, Sakamoto K, Kashiwabara H, Yokoyama T, Ikeda K, Horiuchi S.

Clin Nephrol. 1998 May;49(5):273-80.

PMID:
9617488
6.
7.

Advanced glycation end products accumulate in the reproductive tract of men with diabetes.

Mallidis C, Agbaje IM, Rogers DA, Glenn JV, Pringle R, Atkinson AB, Steger K, Stitt AW, McClure N.

Int J Androl. 2009 Aug;32(4):295-305. doi: 10.1111/j.1365-2605.2007.00849.x. Epub 2008 Jan 22.

PMID:
18217985
8.

Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.

Sady C, Jiang CL, Chellan P, Madhun Z, Duve Y, Glomb MA, Nagaraj RH.

Biochim Biophys Acta. 2000 Sep 29;1481(2):255-64.

PMID:
11018716
9.

Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.

Shibayama R, Araki N, Nagai R, Horiuchi S.

Diabetes. 1999 Sep;48(9):1842-9.

PMID:
10480617
10.

Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.

van de Kerkhof J, Schalkwijk CG, Konings CJ, Cheriex EC, van der Sande FM, Scheffer PG, ter Wee PM, Leunissen KM, Kooman JP.

Nephrol Dial Transplant. 2004 Apr;19(4):910-6.

11.

The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.

Murata T, Nagai R, Ishibashi T, Inomuta H, Ikeda K, Horiuchi S.

Diabetologia. 1997 Jul;40(7):764-9.

PMID:
9243096
12.

Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.

Endo M, Yanagisawa K, Tsuchida K, Okamoto T, Matsushita T, Higuchi M, Matsuda A, Takeuchi M, Makita Z, Koike T.

Horm Metab Res. 2001 May;33(5):317-22.

PMID:
11440280
13.

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.

Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C.

Kidney Int. 1997 Apr;51(4):1170-81.

PMID:
9083283
14.

Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.

Choi YG, Lim S.

J Immunoassay Immunochem. 2009;30(4):386-99. doi: 10.1080/15321810903188136.

PMID:
19739013
15.

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

Berg TJ, Clausen JT, Torjesen PA, Dahl-Jørgensen K, Bangstad HJ, Hanssen KF.

Diabetes Care. 1998 Nov;21(11):1997-2002.

PMID:
9802757
16.

Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody.

Schalkwijk CG, Baidoshvili A, Stehouwer CD, van Hinsbergh VW, Niessen HW.

Biochim Biophys Acta. 2004 Mar 22;1636(2-3):82-9.

PMID:
15164755
18.

Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.

Swamy-Mruthinti S, Miriam KC, Kumar SK, Biswas J, Ramakrishnan S, Nagaraj RH, Sulochana KN.

Curr Eye Res. 2002 Sep;25(3):139-45.

PMID:
12607183
19.

Different role of advanced glycation end products in pathology of transplanted heart in patients with or without diabetes mellitus type 2.

Zakliczynski M, Nozynski J, Konecka-Mrowka D, Pyka L, Trybunia D, Nikiel B, Mlynarczyk-Liszka J, Lange D, Zembala M.

Transplant Proc. 2009 Oct;41(8):3185-9. doi: 10.1016/j.transproceed.2009.07.069.

PMID:
19857706
20.

Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine.

van Heijst JW, Niessen HW, Hoekman K, Schalkwijk CG.

Ann N Y Acad Sci. 2005 Jun;1043:725-33.

PMID:
16037299
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk